When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.

Published Date: 15 Dec 2023

Improvements in 2-year PFS and OS, but not for primary refractory illness.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Safe and acceptable telehealth suicide prevention program.

2.

Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

3.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

4.

Renewing the call for a national Cancer Patient's Bill of Rights

5.

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot